Dennison Manufacturing Co. v. Panduit Corp.
Cases that cite this one
65 later published cases cite this decision. The 25 that cite it most often are listed here.
- Teva Pharm. United States, Inc. v. Sandoz, Inc. (Supreme Court of the United States 2015)
- Abbott Laboratories v. Sandoz, Inc. (Fed. Cir. 2008)
- Micron Technology, Inc. v. Rambus Inc. (Fed. Cir. 2011)
- Golden Hour Data Systems, Inc. v. emsCharts, Inc. (Fed. Cir. 2010)
- Edward H. Phillips v. Awh Corporation, Hopeman Brothers, Inc., and Lofton Corporation, Defendants-Cross (Fed. Cir. 2006)
- Harold L. Bowers (Doing Business as Hlb Technology), Plaintiff-Cross v. Baystate Technologies, Inc. (Fed. Cir. 2003)
- Litton Systems, Inc. v. Honeywell, Inc., Defendant/cross-Appellant (Fed. Cir. 1996)
- Hughes Aircraft Co. v. United States (Court of Claims 1988)
- Panduit Corporation v. Dennison Manufacturing Co. (Fed. Cir. 1987)
- Al-Site Corporation and Magnivision, Inc. v. Vsi International, Inc. And Myron Orlinsky, Defendants-Cross (Fed. Cir. 1999)
- General Elec. Co. v. Nintendo Co., Ltd. (District Court, D. New Jersey 1997)
- Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. (Supreme Court of the United States 2015)
- The Dow Chemical Company v. Nova Chemicals Corporation (Fed. Cir. 2015)
- Lighting Ballast Control LLC v. Philips Electronics North America Corp. (Fed. Cir. 2014)
- Allen Archery, Inc. v. Browning Manufacturing Co. (Fed. Cir. 1987)
- Libbey-Owens-Ford Co. v. BOC Group, Inc. (District Court, D. New Jersey 1987)
- Allen Archery, Inc. v. Browning Manufacturing Co. (Fed. Cir. 1987)
- ABS Global, Inc. v. Inguran, LLC (7th Cir. 2019)
- Broussard v. Go-Devil Manufacturing Co. of LA., Inc. (District Court, M.D. Louisiana 2014)
- Eurand, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2012)
- Bone Care International, LLC v. Pentech Pharmaceuticals, Inc. (District Court, N.D. Illinois 2012)
- Pfizer Inc. v. Teva Pharmaceuticals USA, Inc. (District Court, E.D. Virginia 2011)
- Transocean Offshore Deepwater Drilling, Inc. v. Maersk Contractors USA, Inc. (Fed. Cir. 2010)
- Krippelz v. Ford Motor Co. (District Court, N.D. Illinois 2010)
- International Seaway Trading Corp. v. Walgreens Corp. (United States District Court for the Southern District of Florida 2009)
This list shows which later cases cite this one. It does not say how they treated it, and no review of that has been done. Not a substitute for Shepard’s or KeyCite — verify before relying.
Opinion of the Court
Respondent holds three patents for plastic cable ties, products that are commercially successful. Petitioner copied respondent’s products, was sued for patent infringement in the Northern District of Illinois, and defended on the ground that the patents were invalid for obviousness. The trial
The Court of Appeals for the Federal Circuit reversed. 774 F. 2d 1082 (1985). The court disagreed with the District Court’s assessment of the prior art, ruled that the references cited by the District Court did not teach the innovations introduced by respondent, and referred to other errors made by the District Court.
Petitioner contends that the Federal Circuit ignored Federal Rule of Civil Procedure 52(a) in substituting its view of factual issues for that of the District Court. In particular, petitioner complains of the rejection of the District Court’s determination of what the prior art revealed and its findings that the differences identified between respondent’s patents and the prior art were obvious.
Petitioner’s claims are not insubstantial. As this Court observed in Graham v. John Deere Co., 383 U. S. 1, 17-18 (1966):
“While the ultimate question of patent validity is one of law, . . . the §103 condition [that is, nonobviousness] . . . lends itself to several basic factual inquiries. Under § 103, the scope and content of the prior art are to be*811 determined; differences between the prior art and the claims at issue are to be ascertained; and the level of ordinary skill in the pertinent art resolved. Against this background, the obviousness or nonobviousness of the subject matter is determined. Such secondary considerations as commercial success, long felt but unresolved needs, failure of others, etc., might be utilized to give light to the circumstances surrounding the origin of the subject matter sought to be patented. As indicia of obviousness or nonobviousness, these inquiries may have relevancy.”
This description of the obviousness inquiry makes it clear that whether or not the ultimate question of obviousness is a question of fact subject to Rule 52(a), the subsidiary determinations of the District Court, at the least, ought to be subject to the Rule.
The Federal Circuit, however, did not mention Rule 52(a), did not explicitly apply the clearly-erroneous standard to any of the District Court’s findings on obviousness, and did not explain why, if it was of that view, Rule 52(a) had no applicability to this issue. We therefore lack an adequate explanation of the basis for the Court of Appeals’ judgment: most importantly, we lack the benefit of the Federal Circuit’s informed opinion on the complex issue of the degree to which the obviousness determination is one of fact. In the absence of an opinion clearly setting forth the views of the Court of Appeals on these matters, we are not prepared to give plenary consideration to petitioner’s claim that the decision below cannot be squared with Rule 52(a). Instead, we grant the petition for certiorari, vacate the judgment, and remand the case to the Court of Appeals for further consideration in light of Rule 52(a).
It is so ordered.
Dissenting Opinion
dissents from this summary disposition, which has been ordered without affording the parties
Case-law data current through December 31, 2025. Source: CourtListener bulk data.